Getting it Right in Crohn’s Disease: A Clinical Guideline and Decision Tool-Based Approach (part 2 of 2)
Program Overview
Despite evidence supporting usefulness of patient-specific risk stratification and personalized treatment, many patients with Crohn’s disease continue to be undertreated. In this activity, learners will explore new and available tools to help risk stratify patients with Crohn’s disease, predict the likelihood of response to various biologic therapies, and select appropriate treatment using these tools and AGA guidelines and care pathways. This activity provides tool demonstrations, video commentary, and case presentations all in one interactive, self-paced infographic.
Gastroenterologists and primary care clinicians involved in the care of patients with inflammatory bowel disease (IBD).
Educational Objectives
Upon completion of this activity, participants should be better able to:
Employ standards of care for the management of inflammatory bowel disease (IBD) as presented in current guidelines
Apply IBD clinical decision support tools to risk stratify patients and aid in therapeutic selection
Select IBD therapies based on risk stratification and guideline recommendations
Activity Faculty
Parambir S. Dulai, MD
Associate Professor, Medicine Director, GI Clinical Trials Director, Precision Medicine
Division of Gastroenterology & Hepatology
Feinberg School of Medicine Northwestern University
Evanston, IL
Corey A. Siegel, MD, MS
Professor of Medicine and of The Dartmouth Institute for Health Policy and Clinical Practice
Geisel School of Medicine at Dartmouth Section Chief, Gastroenterology and Hepatology Co-Director, IBD Center
Dartmouth-Hitchcock Medical Center
Hanover, NH